This inventor holds 16 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Cipla Limited. Active years: 2012-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Maharashtra, IN (2013 - 2015)
- Thane (W), IN (2016)
- Thane (West) Maharashtra, IN (2016)
- Thane, IN (2018)
- Mumbai, IN (2012 - 2019)
Company Filing History:
Years Active: 2012-2024
Areas of Expertise:
Title: Maruti Ganpati Ghagare: Maharashtra's Innovative Patent Maven
Introduction:
Maruti Ganpati Ghagare, a brilliant inventor and patent expert hailing from Maharashtra, India, has made significant strides in the field of pharmaceuticals. With an impressive track record consisting of 14 patents, Ghagare has continuously pushed the boundaries of innovation, particularly in the realm of complex pharmaceutical compositions. Currently affiliated with Cipla Limited, one of India's leading pharmaceutical companies, Ghagare's contributions have earned him recognition both nationally and internationally.
Latest Patents:
Ghagare's most recent patents revolve around rifaximin complexes. These complexes comprise rifaximin, a potent antibiotic, and a complexing agent such as polyvinyl pyrrolidone (PVP) or a cyclodextrin. In addition to the complex itself, Ghagare has developed a novel process for preparing these complexes. The pharmacy industry has also welcomed the therapeutic uses and pharmaceutical compositions based on these rifaximin complexes, which exhibit enhanced efficacy and improved patient outcomes.
Career Highlights:
Ghagare's career breakthroughs reflect his commitment to advancing pharmaceutical innovations. Through his extensive research and development efforts, he has successfully obtained 14 patents, representing a significant contribution to the industry and society. His inventions in the field of complex pharmaceutical compositions continue to pave the way for improved treatments and therapies.
Collaborations:
Ghagare has collaborated with esteemed colleagues to further propel his innovative ideas. Notable among his collaborators are Rajendra Narayanrao Kankan and Dharmaraj Ramachandra Rao. Together, they have worked towards optimizing drug delivery systems and expanding the applications of rifaximin complexes. Ghagare's ability to foster partnerships and collaborate shows his dedication towards creating effective solutions for the pharmaceutical sector.
Conclusion:
Maruti Ganpati Ghagare's impressive repertoire of patents and inventions solidify his position as an influential figure in the field of pharmaceutical innovations. His expertise in developing rifaximin complexes and other complex pharmaceutical compositions has significantly impacted the industry, imprinting value-added advancements onto therapeutic solutions. We can expect Ghagare to continue driving progress in the world of pharmaceutical research and development, continuously striving for groundbreaking discoveries that benefit patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile